Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Short Interest Update

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 60,900 shares, an increase of 1,168.8% from the February 29th total of 4,800 shares. Based on an average daily volume of 2,262,900 shares, the days-to-cover ratio is currently 0.0 days.

Innovation Pharmaceuticals Stock Performance

IPIX remained flat at $0.01 during trading hours on Wednesday. 88,970 shares of the company were exchanged, compared to its average volume of 833,622. Innovation Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $0.03. The business’s fifty day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

About Innovation Pharmaceuticals

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.